Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

(-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats

Producción científica: Article › revisión exhaustiva

33 Citas (Scopus)

Resumen

Rats were trained in a two-lever food-reinforced operant task to discriminate (+)-amphetamine (1 mg/kg) from saline. After discrimination training stabilized, test doses of (+)-amphetamine (0.0625-2.0 mg/kg), (-)-nicotine (0.1-1.0 mg/kg), or (-)-nornicotine (1-10 mg/kg) were assessed for their ability to substitute for the (+)-amphetamine training dose during brief test sessions in which food reinforcement was withheld. As expected, as the test dose of (+)-amphetamine increased, there was a dose-related increase in drug-appropriate responding, with both 1 and 2 mg/kg test doses substituting fully for the (+)-amphetamine training dose. Both (-)-nicotine and (-)-nornicotine showed partial substitution (approximately 50% drug-appropriate responding) for the (+)-amphetamine training dose, with (-)-nicotine being more potent than (-)-nornicotine. Rate suppressant effects prevented the assessment of higher doses of (-)-nicotine or (-)-nornicotine. Thus, while (-)-nicotine and (-)-nornicotine share similar discriminative stimulus properties, the mechanism that mediates this effect appears to differ, at least in part, from that activated by (+)-amphetamine.

Idioma originalEnglish
Páginas (desde-hasta)1083-1087
Número de páginas5
PublicaciónPharmacology Biochemistry and Behavior
Volumen58
N.º4
DOI
EstadoPublished - dic 1997

Nota bibliográfica

Funding Information:
This work was supported in part by grants from the Tobacco & Health Research Institute (Lexington, KY) and the National Institutes on Health (DA 05312). The expert technical assistance of M. Marion and consultation of J. Rowlett is appreciated.

Financiación

This work was supported in part by grants from the Tobacco & Health Research Institute (Lexington, KY) and the National Institutes on Health (DA 05312). The expert technical assistance of M. Marion and consultation of J. Rowlett is appreciated.

FinanciadoresNúmero del financiador
Tobacco and Health Research Institute
Foundation for the National Institutes of HealthDA 05312
National Institute on Drug AbuseP50DA005312

    ASJC Scopus subject areas

    • Biochemistry
    • Toxicology
    • Pharmacology
    • Clinical Biochemistry
    • Biological Psychiatry
    • Behavioral Neuroscience

    Huella

    Profundice en los temas de investigación de '(-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats'. En conjunto forman una huella única.

    Citar esto